Skip to main content

Table 2 Measures used at baseline, one-and five-years in the ADDITION-Cambridge

From: The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients

Measures

Baseline

1-year

5-year

 

C

RC

IT

C

RC

IT

C

RC

IT

Diabetes risk score calculation

X

X

X

      

Questionnaires measures

         

1. Ethnic group, occupation, educational level and social class

 

X

X

      

2 Smoking status, alcohol consumption

 

X

X

 

X

X

X

X

X

3. Rose angina questionnaire [51]

 

X

X

   

X

  

4. Self-reported history of angina, heart attack and stroke

 

X

X

 

X

X

X

X

X

5. Medication adherence:

         

   All drugs during the last month [40]

 

X

X

 

X

X

 

X

X

   Hypoglycaemic drugs during the last month [40]

    

X

X

 

X

X

6. EuroQoL EQ-5D [47] & SF-36 [45]/SF-8 [46]

 

X

X

 

X

X

X

X

X

7. Diabetes related quality of life: ADDQoL [44], Diabetes well-being: W-BQ 28 [44], Diabetes treatment satisfaction: DTSQ[44]

    

X

X

 

X

X

8. Spiegelberger Short form State Anxiety inventory [49]

 

X

X

 

X

X

   

9. Consultation and relational empathy measure: CARE [48]

 

X

X

 

X

X

   

10. Diabetes knowledge †

    

X

X

   

11. EPAQ-2 [41]

 

X

X

 

X

X

 

X

X

12. IPAQ [42]

 

X

X

 

X

X

X

X

X

13. EPIC food frequency questionnaire [43]

 

X

X

 

X

X

 

X

X

14. Brief dietary questionnaire (adapted from the EPIC food frequency questionnaire) †

      

X

X

X

15. Costs comprising:

         

   Personal patient costs †

 

X

X

      

   Health Service and medication use previous 3 months (adapted from the Aberdeen Health Service Research Unit questionnaire) †

    

X

X

X

X

X

16. Neuropathy questionnaire (adapted from the Michigan Screening Instrument) †

 

X

X

 

X

X

 

X

X

Biological measures

         

17. Waist circumference, height, weight, blood pressure, body fat impedance and ECG

 

X

X

 

X

X

 

X

X

18. Fasting capillary blood glucose

 

X

X

      

19. Fasting, 30 and 120 min: venous whole blood glucose (OGTT), plasma glucose, plasma insulin.

 

X

X

      

20. HbA1c, total cholesterol, HDL and LDL cholesterol, triglyceride, Vitamin C, Urinalysis, Urine albumin/creatinine ratio, Urea and Electrolytes, Creatinine, Albumin, Biliribin, Alanine Amino Transferanse (ALT), Alkaline Phosphatase, Aspartate Amino Transferase (AST), Thyroid Stimulating Hormone (TSH)

 

X

X

 

X

X

 

X

X

21. Modelled CVD risk calculated with the UKPDS risk engine [39]

 

X

X

 

X

X

 

X

X

22. Stereoscopic fundal photography

       

X

X

23. Mortality

      

X

X

X

  1. †: Questionnaire developed for the study
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us